Takeda Pharmaceutical (TAK) Other Non-Current Assets (2017 - 2026)
Takeda Pharmaceutical (TAK) recorded Other Non-Current Assets of $503.8 million in the quarter ended Jun 30, 2026, up 6.3% from $473.79 million a year earlier and up 2.6% from the prior quarter.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Other Non-Current Assets (2017 - 2026) Analysis & Trends
As of Mar 31, 2026, Takeda Pharmaceutical reported Other Non-Current Assets of $511.59 million, up 10.9% from the prior year.
- Annual Other Non-Current Assets has a five-year compound annual growth rate of -11.6% (years ended Mar 2021 to Mar 2026).
- Across earlier years, Other Non-Current Assets came in at $461.39 million in the year ended Mar 31, 2025 (+29.9%), $355.12 million in the year ended Mar 31, 2024 (-24.2%), $468.75 million in the year ended Mar 31, 2023 (-36.3%) and $735.81 million in the year ended Mar 31, 2022 (-22.3%).
- Quarterly Other Non-Current Assets has ranged from $345.58 million in the quarter ended Mar 31, 2024 to $710.86 million in the quarter ended Mar 31, 2022 over the past five years.
- On a year-over-year basis, Other Non-Current Assets has increased for three consecutive quarters, with growth averaging 9.1% over the last eight quarters.
- Peak year-over-year performance for Other Non-Current Assets in the last five years was growth of 55.3% in the quarter ended Jun 30, 2024, against a decline of 33.0% in the quarter ended Jun 30, 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $491.06 million (quarter ended Mar 31, 2026), $505.52 million (quarter ended Dec 31, 2025) and $478.68 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Takeda Pharmaceutical | 2.63 Bn | -23.88 Bn | 5.10 Bn | 503.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 503.80 Mn |
| Mar 31, 2026 | 491.06 Mn |
| Dec 31, 2025 | 505.52 Mn |
| Sep 30, 2025 | 478.68 Mn |
| Jun 30, 2025 | 473.79 Mn |
| Mar 31, 2025 | 460.67 Mn |
| Dec 31, 2024 | 487.79 Mn |
| Sep 30, 2024 | 569.96 Mn |
| Jun 30, 2024 | 681.56 Mn |
| Mar 31, 2024 | 345.58 Mn |
| Dec 31, 2023 | 370.08 Mn |
| Sep 30, 2023 | 413.19 Mn |
| Jun 30, 2023 | 438.86 Mn |
| Mar 31, 2023 | 478.73 Mn |
| Dec 31, 2022 | 472.65 Mn |
| Sep 30, 2022 | 584.30 Mn |
| Jun 30, 2022 | 654.76 Mn |
| Mar 31, 2022 | 710.86 Mn |
| Jun 30, 2021 | 868.03 Mn |
| Mar 31, 2021 | 947.97 Mn |
API Access
Takeda Pharmaceutical Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();